STOCK TITAN

S&P Global Enhances Capital IQ Pro with Expanded Fixed Income, Biopharma and Private Markets Data Content and AI Capabilities

(Moderate)
(Very Positive)
Tags
AI

S&P Global (NYSE: SPGI) expanded S&P Capital IQ Pro on March 12, 2026 with enhanced AI and data coverage, adding ProntoNLP sentiment analytics, acquiring Drift AI for Excel-based natural-language financial modeling, and enlarging fixed income, biopharma and private markets datasets to accelerate research and decision making.

Key additions include >4 million structured securities, security-level fixed income ownership, Visible Alpha biopharma analytics, and 20,000 private-markets documents in Document Intelligence.

Loading...
Loading translation...

Positive

  • Added over 4 million structured fixed-income securities
  • Acquired Drift AI to integrate natural-language financial modeling into Excel
  • Integrated ProntoNLP sentiment analysis into Document Intelligence
  • Added security-level fixed income ownership data for granular holder insights
  • Ingested 20,000 private-markets documents into Gen-AI Document Intelligence

Negative

  • None.
Argus Mar 12 session
-2.16% close to close Open Argus
Details

News Market Reaction – SPGI

In the Mar 12 session, SPGI declined 2.16%, reflecting a moderate negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

Market Context

This announcement underscores SPGI’s continued push to embed AI and richer datasets into Capital IQ ...
Analysis

This announcement underscores SPGI’s continued push to embed AI and richer datasets into Capital IQ Pro, adding over 4 million structured securities, 20,000 private-markets documents, and Drift AI’s Excel modeling capabilities. In the context of prior AI-tagged reports that averaged 0.49% one-day moves, it represents another incremental step in a broader AI strategy. Investors may watch adoption of new sentiment tools, fixed income ownership data usage, and biopharma analytics traction.

Key Figures

New structured securities: over 4 million securities Existing fixed income universe: 20 million+ securities Private markets documents: 20,000 documents +3 more
New structured securities
over 4 million securities
Structured securities from Markit added to fixed income coverage
Existing fixed income universe
20 million+ securities
Previously added fixed income securities across Loans, Munis, GSAC
Private markets documents
20,000 documents
Investment Committee packs, tender docs and LP filings added
Drift AI acquisition
1 platform acquired
Acquisition of Drift AI to enhance Capital IQ Pro Excel Plugin
ProntoNLP acquisition year
2025
Year S&P Global acquired ProntoNLP for AI and NLP capabilities
Headcount analytics expansion
broader coverage
Expanded workforce-based metrics for companies with limited financial data

Previous AI Reports

5 past events · Latest: Feb 17
Same Type 5 events
  1. Feb 17

    AI liquidity outlook

    24h Move
    +0.2%

    Ratings unit published Liquidity Outlook 2026 focused on AI and credit markets.

  2. Jan 08

    AI-driven copper study

    24h Move
    +0.8%

    Study projected 2040 copper demand and AI-related supply-demand imbalances.

  3. Dec 17

    AI youth initiative

    24h Move
    +2.1%

    Launched StepForward, a $10M philanthropic AI workforce readiness program.

  4. Dec 09

    AI energy trends

    24h Move
    -0.3%

    Energy unit released AI-driven power demand and clean energy market trends.

  5. Nov 05

    AI agent outlook

    24h Move
    -0.4%

    Report on enterprise race to build AI agent-ready infrastructure and GPU demand.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Key Terms

structured securities, clinical trial
2 terms
structured securities financial
"Added over 4 million structured securities from Markit, featuring enhanced pricing..."
Structured securities are investment products created by combining basic financial pieces — such as loans, bonds, or contracts whose payouts depend on future events — into a single package with a tailored payoff formula. Think of them as a custom recipe that mixes ingredients to produce a specific taste: they can offer higher yields or targeted exposure but also carry extra complexity and risk tied to the underlying assets and the product’s design. Investors need to weigh potential return against credit, market, and liquidity risks.
clinical trial medical
"including drug pipeline data, clinical trial insights, regulatory timelines..."
A clinical trial is a carefully controlled study in which a new medicine, medical device, or treatment is tested on people to see if it is safe and effective. For investors it matters because trial results determine whether a product can win regulatory approval and reach patients, much like a road test decides if a new car can be sold; positive or negative results can sharply change a company’s prospects and stock value.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

Drift AI acquisition and the integration of ProntoNLP boost platform's GenAI tooling for enhanced client impact

  • Adds ProntoNLP sentiment analysis to AI-powered Document Intelligence and over 4 million structured securities to accelerate financial analysis 
  • Acquires Drift AI to integrate natural language financial modeling into Capital IQ Pro Excel Plugin 

NEW YORK, March 12, 2026 /PRNewswire/ -- S&P Global (NYSE: SPGI) today announced significant enhancements to its flagship S&P Capital IQ Pro platform that incorporate advanced artificial intelligence capabilities and expanded datasets to accelerate financial analysis and decision making. The updates include the addition of ProntoNLP analytics along with data expansions across fixed income, biopharma and private markets. Additionally, S&P Global announced the acquisition of Drift AI, an AI-powered Excel solution, with planned integration into the platform.

The enhancements reinforce S&P Capital IQ Pro's position as a comprehensive platform that delivers trusted data, connected technology and AI-powered tools that support research, client coverage, idea generation and risk management workflows. 

AI-Powered Research Acceleration

S&P Capital IQ Pro now includes ProntoNLP advanced sentiment analysis within Document Intelligence, Capital IQ Pro's AI-powered document analysis tool—enabling users to quickly access and assess the important themes and related sentiment in earnings call transcripts and associated documents. The enhanced functionality builds on S&P Global's 2025 acquisition of ProntoNLP, which brought advanced AI and NLP capabilities to better analyze and gain insights from textual data.

"We continue to deliver new AI-powered capabilities directly into Capital IQ Pro while also unlocking the platform to support new and compelling agentic use cases and opportunities," said Warren Breakstone, Head of Data & Research at S&P Market Intelligence. "The addition of ProntoNLP, and now DriftAI, are two of the latest examples of recent advancements. At the same time, we continue to invest heavily in adding new and differentiated data to enhance client decision making and bring these AI-powered capabilities to life."

Enhanced Data Coverage Across Key Markets

Additional data and capabilities expand the platform's analytical depth across multiple asset classes:

  • Expansion of Fixed Income Coverage: Added over 4 million structured securities from Markit, featuring enhanced pricing, analytics and liquidity data, along with more granular reference information such as collateral type and advisor roles. In previous releases, 20 million+ Fixed Income Securities across Loans, Munis, Government, Sovereign, Agency and Corporates (GSAC) were added to the platform.
  • Security-Level Fixed Income Ownership Data: New granular ownership insights provide detailed holder information at the individual security level, enabling fixed income analysts to track institutional positioning, identify concentration risks and understand ownership patterns across bond markets.
  • Visible Alpha Biopharma: Integration of comprehensive pharmaceutical sector coverage delivers specialized analytics including drug pipeline data, clinical trial insights, regulatory timelines and market forecasts to support investment decisions in the rapidly evolving healthcare sector.
  • Expanded Private Markets Collection: Added 20,000 Investment Committee meeting packs, tender documents and LP filings to Gen-AI powered Document Intelligence. This is the first major integration of With Intelligence content into Capital IQ Pro and allows users to assess LP allocation strategies, track their evolution over time and help GPs inform their fundraising processes.
  • Expanded Headcount Analytics: The platform now provides broader coverage of workforce-based metrics for evaluating companies when private company financial data is limited, featuring more intuitive connectivity between fund sponsors, funds and fund managers' screening results.

Drift AI Acquisition

S&P Global acquired Drift AI (formerly Arkifi), an AI-powered Excel analysis solution that automates financial modeling workflows. The acquisition further accelerates AI enhancements in S&P Capital IQ Pro with plans to integrate Drift AI capabilities into the Capital IQ Pro Excel Plugin. Drift AI's technology enables natural language building and querying of financial models, enriches spreadsheets with contextual insights and helps users quickly identify trends, validate assumptions and cross-check materials.

For more information on S&P Capital IQ Pro, please see here.

To learn more about Artificial Intelligence at S&P Global, please visit here.

Media Contacts:

Orla O'Brien
S&P Global
+1 857 407 8559
orla.obrien@spglobal.com

Florence Bogitsh
S&P Global Market Intelligence
+1 646 460-7204
florence.bogitsh@spglobal.com
press.mi@spglobal.com

About S&P Global 

S&P Global (NYSE: SPGI) enables businesses, governments, and individuals with trusted data, expertise and technology to make decisions with conviction. We are Advancing Essential Intelligence through world-leading benchmarks, data, and insights that customers need in order to plan confidently, act decisively, and thrive economically in a rapidly changing global landscape.   

From helping our customers assess new investments across the capital and commodities markets to guiding them through the energy expansion, acceleration of artificial intelligence, and evolution of public and private markets, we enable the world's leading organizations to unlock opportunities, solve challenges, and plan for tomorrow – today. Learn more at www.spglobal.com

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/sp-global-enhances-capital-iq-pro-with-expanded-fixed-income-biopharma-and-private-markets-data-content-and-ai-capabilities-302711573.html

SOURCE S&P Global

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did S&P Global (SPGI) announce on March 12, 2026 about Capital IQ Pro?

S&P Global announced expanded AI tools and datasets for Capital IQ Pro on March 12, 2026. According to the company, enhancements include ProntoNLP sentiment analytics, the acquisition of Drift AI, >4 million added structured securities, biopharma analytics and 20,000 private-markets documents.

How will the Drift AI acquisition affect Capital IQ Pro Excel workflows for SPGI users?

Drift AI will add natural-language model building and querying inside Excel for Capital IQ Pro. According to the company, integration plans will automate financial modeling, enrich spreadsheets with contextual insights and speed trend identification and assumption validation.

What fixed income data enhancements did S&P Global (SPGI) add to Capital IQ Pro?

Capital IQ Pro added over 4 million structured securities and security-level ownership data. According to the company, additions include pricing, analytics, collateral details and granular holder information to support bond positioning and concentration analysis.

What biopharma capabilities does Capital IQ Pro now offer after the March 12, 2026 update?

The platform now includes Visible Alpha biopharma analytics covering pipelines, trial results and regulatory timelines. According to the company, these tools deliver clinical trial insights and market forecasts to inform healthcare investment decisions.

How did S&P Global expand private markets content in Capital IQ Pro on March 12, 2026?

S&P Global added 20,000 Investment Committee packs, tender documents and LP filings to Document Intelligence. According to the company, this first major With Intelligence integration helps users assess LP allocation strategies and fundraising-related trends.

Keep reading